Drug Repurposing Market was valued at USD 23.5 Billion in 2022 and is projected to reach USD 47.8 Billion by 2030, growing at a CAGR of 9.4% from 2024 to 2030.
In comparison, the outlook for the drug repurposing market from 2023 to 2033 is expected to expand even further, fueled by advancements in technology and a better understanding of drug mechanisms. The increasing prevalence of chronic diseases, along with the growing focus on personalized medicine, is expected to drive the demand for repurposed drugs. Furthermore, breakthroughs in artificial intelligence (AI) and machine learning are predicted to accelerate the identification of potential drug repurposing candidates. The cost-effectiveness of drug repurposing will continue to appeal to pharmaceutical companies and healthcare providers, as repurposed drugs often have a faster time to market and lower clinical trial costs compared to novel drugs. As the market grows, there will be a greater focus on regulatory challenges, intellectual property concerns, and the integration of repurposing efforts into clinical practice.
Looking ahead, drug repurposing will not only play a key role in addressing urgent health needs but also contribute to the broader trend of sustainable healthcare solutions. The market is expected to evolve with more strategic collaborations and partnerships between pharmaceutical companies, academic institutions, and regulatory bodies. The demand for innovative repurposing strategies will likely increase as new diseases emerge and the global healthcare landscape continues to shift. Furthermore, the integration of digital health tools and real-world evidence will facilitate the identification of new repurposing opportunities, improving the overall success rate of these efforts.
Get an In-Depth Research Analysis of the Global Drug Repurposing Market Size And Forecast [2025-2032]
The drug repurposing market, a growing trend in the pharmaceutical industry, has seen significant changes between 2018 and 2022. During this period, drug repurposing was primarily driven by the urgent need for new treatments and the availability of existing, approved drugs that could address emerging health challenges. The rising cost of drug development and the growing demand for faster, more cost-effective solutions pushed pharmaceutical companies to look for new uses for existing drugs. This demand was especially visible in the wake of the COVID-19 pandemic, where drug repurposing became a key strategy to rapidly address the global health crisis. The market witnessed several collaborations, partnerships, and initiatives to identify promising candidates for repurposing, contributing to a surge in the number of drug trials and approvals for new indications.
Pfizer
Roche
Novartis AG
Abbott Healthcare
Johnson & Johnson
Sandoz
Mylan Inc.
Teva Pharmaceuticals
By the year 2030, the scale for growth in the market research industry is reported to be above 120 billion which further indicates its projected compound annual growth rate (CAGR), of more than 5.8% from 2023 to 2030. There have also been disruptions in the industry due to advancements in machine learning, artificial intelligence and data analytics There is predictive analysis and real time information about consumers which such technologies provide to the companies enabling them to make better and precise decisions. The Asia-Pacific region is expected to be a key driver of growth, accounting for more than 35% of total revenue growth. In addition, new innovative techniques such as mobile surveys, social listening, and online panels, which emphasize speed, precision, and customization, are also transforming this particular sector.
Get Discount On The Purchase of the Global Drug Repurposing Market Size And Forecast [2025-2032]
Growing demand for below applications around the world has had a direct impact on the growth of the Global Drug Repurposing Market
Cardiovascular Disorders
Central Nervous Disorders
Oncology
Others
Based on Types the Market is categorized into Below types that held the largest Drug Repurposing market share In 2023.
Intravenous
Oral
Global (United States, Global and Mexico)
Europe (Germany, UK, France, Italy, Russia, Turkey, etc.)
Asia-Pacific (China, Japan, Korea, India, Australia, Indonesia, Thailand, Philippines, Malaysia and Vietnam)
South America (Brazil, Argentina, Columbia, etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
For More Information or Query, Visit @ Drug Repurposing Market Research Analysis
1. Introduction of the Global Drug Repurposing Market
Overview of the Market
Scope of Report
Assumptions
2. Executive Summary
3. Research Methodology of Verified Market Reports
Data Mining
Validation
Primary Interviews
List of Data Sources
4. Global Drug Repurposing Market Outlook
Overview
Market Dynamics
Drivers
Restraints
Opportunities
Porters Five Force Model
Value Chain Analysis
5. Global Drug Repurposing Market, By Type
6. Global Drug Repurposing Market, By Application
7. Global Drug Repurposing Market, By Geography
Global
Europe
Asia Pacific
Rest of the World
8. Global Drug Repurposing Market Competitive Landscape
Overview
Company Market Ranking
Key Development Strategies
9. Company Profiles
10. Appendix
About Us: Verified Market Reports
Verified Market Reports is a leading Global Research and Consulting firm servicing over 5000+ global clients. We provide advanced analytical research solutions while offering information-enriched research studies. We also offer insights into strategic and growth analyses and data necessary to achieve corporate goals and critical revenue decisions.
Our 250 Analysts and SMEs offer a high level of expertise in data collection and governance using industrial techniques to collect and analyze data on more than 25,000 high-impact and niche markets. Our analysts are trained to combine modern data collection techniques, superior research methodology, expertise, and years of collective experience to produce informative and accurate research.
Contact us:
Mr. Edwyne Fernandes
US: +1 (650)-781-4080
US Toll-Free: +1 (800)-782-1768
Website: https://www.verifiedmarketreports.com/